2010
DOI: 10.1016/j.biopsych.2010.04.013
|View full text |Cite
|
Sign up to set email alerts
|

Assessments of Function and Biochemistry of the Anterior Cingulate Cortex in Schizophrenia

Abstract: Background-Neuroimaging and electrophysiological studies have consistently provided evidence of impairment in anterior cingulate cortex (ACC)/medial frontal cortex (MFC) function in people with schizophrenia. In this study, we sought to clarify the nature of this abnormality by combining proton magnetic resonance spectroscopy ( 1 H-MRS) with functional magnetic resonance imaging (fMRI) at 3T.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
100
2
3

Year Published

2011
2011
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 113 publications
(111 citation statements)
references
References 105 publications
6
100
2
3
Order By: Relevance
“…Clinically, these functions are impaired in schizophrenia patients. Convergent results of decreased rCBF in the ACC are consistent with clinical observations and other imaging studies 18 .…”
Section: Discussionsupporting
confidence: 79%
“…Clinically, these functions are impaired in schizophrenia patients. Convergent results of decreased rCBF in the ACC are consistent with clinical observations and other imaging studies 18 .…”
Section: Discussionsupporting
confidence: 79%
“…Nevertheless, this study suggests that high levels of glutamate measured in the precommissural dorsal-caudate nucleus, a region with prominent projections throughout the cortical mantle, could induce cortical neuronal toxicity leading to a progressive functional and intellectual deterioration. Because there is preliminary evidence that stable medicated subjects either do not show a difference or evidence a decrease in glutamate levels compared with normal subjects (de la Fuente-Sandoval et al, 2011;Reid et al, 2010), it is tempting to hypothesize that a time-limited neurotoxic process may characterize the prodromal period and the early stages of the illness. Although more research is needed in this area, this suggests the possibility of curtailing functional deterioration by intervening therapeutically during the early stages.…”
mentioning
confidence: 99%
“…Briefly, the evidence suggests hypofunction of the NMDA receptor, which leads to reduced GABAergic interneuron stimulation but upregulated AMPA receptor signaling. In MRS studies, glutamate metabolite levels vary with the level of negative symptoms (12), cognitive deficits (13), and global functioning (14). These provide direct evidence that Gln/ Glu changes predictably with manipulation of synaptic activity.…”
Section: Bioenergetics and Glutamatergic Neurotransmission In Schizopmentioning
confidence: 87%